In the pre-metastatic microenvironment, CCL2 secreted by cancer cells and bone marrow cells attracts and induces M2-TAM and other cells to activate Wnt/β-catenin signaling pathway, which destroys the E-cadherin junction between early cancer cells. This evidence concerns the gene CCL2 and cancer.